OCT New England 2025
Join us at Outsourcing Clinical Trials New England, happening October 15-16 in Boston, Massachusetts!
Visit booth #80 to meet TFS’s experienced CRO team and explore our specialized clinical development and resourcing solutions designed to elevate your clinical research. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver.
Why TFS?
Experience scientific and medical excellence across diverse therapeutic areas. Our seasoned professionals ensure solution-driven outcomes, allowing sponsors to concentrate on advancing clinical innovations. TFS CRO provides industry-leading capabilities in the following areas:
Our Experts
Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in clinical development. See you at OCT New England 2025!
Attend Our Presentation
From First Step to Final Outcome: Reframing Feasibility as an Operational Strategy
- October 15 at 2:30 PM
- Clinical Outsourcing & Operations Stream
Insights you can expect:
- Understand the difference between traditional feasibility and true operational feasibility, and why that distinction matters.
- Learn how early cross-functional risk assessments can expose delivery risks before they surface mid-study.
- Discover how to align feasibility insights with CRA oversight, site strategy, and TMF readiness from the outset.
- Explore how an integrated feasibility-to-delivery model can improve performance in high-complexity, high-variability trials.
Feasibility is often treated as a checklist exercise, focused on data collection and projections. But in today’s increasingly complex trials, true operational feasibility must go further. This session examines how integrating cross-functional risk assessment into the feasibility process can enhance site strategy, CRA oversight, TMF planning, and long-term trial delivery. Attendees will learn how to identify feasibility approaches that align with execution, not just enrollment, and how a more connected model helped de-risk a complex study. Whether navigating compressed timelines or niche populations, sponsors will leave with practical strategies to elevate feasibility from a planning task to a foundational element of trial success.
About Our Presenter: Jessica Wessel
Jessica Wessel is a Senior Program Director at TFS HealthScience specializing in clinical trial development and operations, with over a decade of experience navigating the biotech, non-profit, large pharma, and global CRO sectors. Drawing on a background in academia, her career has advanced from Research Coordinator to Clinical Scientist and Director of Clinical Operations, where she has overseen clinical trial programs from early-phase development through post-market studies. Her therapeutic expertise includes Ophthalmology, Neurology, Endocrinology, and Immunology, covering medicinal products, medical devices, advanced therapeutics, and non-interventional trials.